ketoconazole has been researched along with Anemia, Sickle Cell in 3 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We compared our previous protocol of three times daily (TID) KTZ dosing with prednisone for 6 months with our current regimen of initiating KTZ 200 mg TID with prednisone 5 mg daily for 2 weeks and then tapering to KTZ 200 mg nightly for 6 months." | 5.40 | Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes. ( Hoeh, MP; Levine, LA, 2014) |
| " We compared our previous protocol of three times daily (TID) KTZ dosing with prednisone for 6 months with our current regimen of initiating KTZ 200 mg TID with prednisone 5 mg daily for 2 weeks and then tapering to KTZ 200 mg nightly for 6 months." | 1.40 | Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes. ( Hoeh, MP; Levine, LA, 2014) |
| "Hydroxyurea therapy in sickle cell anemia patients maintains fungal species balance in oral cavity." | 1.39 | Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance. ( Braga, JA; Brighenti, FL; Figueiredo, MS; Koga-Ito, CY; Pereira, DF; Salvia, AC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Joice, GA | 1 |
| Liu, JL | 1 |
| Burnett, AL | 1 |
| Hoeh, MP | 1 |
| Levine, LA | 1 |
| Salvia, AC | 1 |
| Figueiredo, MS | 1 |
| Braga, JA | 1 |
| Pereira, DF | 1 |
| Brighenti, FL | 1 |
| Koga-Ito, CY | 1 |
1 review available for ketoconazole and Anemia, Sickle Cell
| Article | Year |
|---|---|
Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-Agonists; Algori | 2021 |
2 other studies available for ketoconazole and Anemia, Sickle Cell
| Article | Year |
|---|---|
Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes.
Topics: 14-alpha Demethylase Inhibitors; Adolescent; Adult; Anemia, Sickle Cell; Clinical Protocols; Emergen | 2014 |
Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antifungal Agents; Antisickling Agents; Candida; Candida gla | 2013 |